Duchenne Muscular Dystrophy (DMD): Clinical Trials

67 trials for Duchenne Muscular Dystrophy (DMD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 recruiting, 15 completed, 8 not yet recruiting, 6 enrolling by invitation. 18 Not applicable, 15 Phase 2, 10 Phase 1, 5 Early Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable18Not yet recruiting 5, Recruiting 4, Completed 3, Enrolling by invitation 2, Unknown 2, Active not recruiting 1, Terminated 1
Phase 215Completed 5, Active not recruiting 2, Enrolling by invitation 2, Not yet recruiting 2, Recruiting 2, Withdrawn 2
Phase 110Completed 4, Recruiting 3, Active not recruiting 1, Not yet recruiting 1, Terminated 1
Early Phase 15Recruiting 3, Active not recruiting 2
Phase 33Completed 1, Recruiting 1, Terminated 1

Follow Duchenne Muscular Dystrophy (DMD): new trials by email Literature Review of Duchenne Muscular Dystrophy (DMD) trials Research Report on Duchenne Muscular Dystrophy (DMD)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Urotherapy Education for Families of Children With Duchenne Muscular Dystrophy
Urotherapy Education - Duchenne Muscular Dystrophy (DMD), Lower Urinary Tract Symptoms (LUTS)
Not applicableNot yet recruitingLokman Hekim University502026-11-012026-09-15
Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy
Semaglutide (Rybelsus®), Placebo - Duchenne Muscular Dystrophy (DMD)
Phase 1 / Phase 2Not yet recruitingVanderbilt University Medical Center302026-09-012026-06-11
Self-Efficacy Enhancement Among Online Support Group of Primary Caregivers of Children With Neuro Muscular Dystrophy
Multicomponent Intervention - Duchenne Muscular Dystrophy (DMD), Spinal Muscular Atrophy (SMA)
Not applicableActive not recruitingAga Khan University342026-08-152026-10-09
Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the Safety and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE)
ENTR-601-44, ENTR-601-45 - Duchenne Muscular Dystrophy (DMD)
Phase 2Not yet recruitingEntrada Therapeutics, Inc.802026-08-012026-07-02
Digital Monitoring of Upper Limb Function in Non-Ambulant DMD
Performance of the Upper Limb (PUL) Test, Brook test, Dynamometric measurements of muscle strength - Duchenne Muscular Dystrophy (DMD)
Not applicableNot yet recruitingCentre Hospitalier Universitaire de Liege502026-07-302026-06-23
Registry for Duchenne and Becker Muscular Dystrophy
Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy
RecruitingDr. Andreas Ziegler15002026-07-132026-10-08
Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
SGLT-2 inhibitor, SGLT2 inhibitor - Duchenne Muscular Dystrophy (DMD)
Phase 1RecruitingVanderbilt University Medical Center102026-07-012026-08-24
A Remote Study Using Technology to Assess Outcomes in DMD
Duchenne Muscular Dystrophy (DMD)
RecruitingUniversity of Oxford602026-06-242026-06-10
The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy (DMD)
RecruitingUniversity of Rochester1052026-06-032026-08-19
Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
Zeleciment Rostudirsen (DYNE-251), Placebo - Duchenne Muscular Dystrophy (DMD), Muscular Dystrophy, Duchenne
Phase 3RecruitingDyne Therapeutics902026-06-012026-05-27
DMD and Gamified Physiotherapy
Gamified Mobile Physiotherapy Exercise Application, Standard Home Exercise Instructions - Duchenne Muscular Dystrophy (DMD)
Not applicableNot yet recruitingBaşak Çağla Arslan462026-05-082026-01-27
Usability and User Experience of a Virtual Reality Rehabilitation Game Platform in Individuals With Duchenne Muscular Dystrophy
Virtual Reality Gameplay Session - Duchenne Muscular Dystrophy (DMD)
Enrolling by invitationIstanbul University62026-04-282026-05-04
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular Dystrophy
BMN 351 - Duchenne Muscular Dystrophy (DMD)
Phase 2Enrolling by invitationBioMarin Pharmaceutical182026-04-202026-07-24
Can External Vagus Nerve Stimulation Reduce Systemic Levels of Inflammatory Mediators in Duchenne Muscular Dystrophy Patients?
Transcutaneous auricular vagus nerve stimulation - Duchenne Muscular Dystrophy (DMD)
Not applicableEnrolling by invitationtaVNS AB202026-04-132026-04-24
Invasive Home Ventilation in Denmark
Neuromuscular Diseases (NMD), ALS (Amyotrophic Lateral Sclerosis)
RecruitingCopenhagen University Hospital, Rigshospitalet4502026-04-132026-04-20
A Study to Evaluate the Safety and Tolerability of Rituxan in Duchenne Muscular Dystrophy
Rituxan treatment - Duchenne Muscular Dystrophy (DMD)
Not applicableNot yet recruitingPeking Union Medical College Hospital52026-03-232026-03-16
Urinary Titin Biomarker in DMD
Descending stair walk - Duchenne Muscular Dystrophy (DMD), Becker's Muscular Dystrophy (BMD)
Not applicableRecruitingChildren's Hospital of Philadelphia502026-03-042026-04-08
Factors Influencing Physical Activity Levels in Children With Duchenne Muscular Dystrophy: An ICF-CY-Based Study
Duchenne Muscular Dystrophy (DMD)
Not yet recruitingHacettepe University302026-02-022026-01-29
DMD Gene Variants and Cardiac Dysfunction in Young Males With Dystrophinopathies
Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy
RecruitingAristotle University Of Thessaloniki652026-01-262026-04-07
The Effect of Dual-tasking Program on Cognitive and Physical Functions and Independence in Activities of Daily Living in Children With Duchenne Muscular Dystrophy: A Single-blind Randomized Controlled Trial
Conventional physiotherapy program, Conventional physiotherapy program + Dual task program - Duchenne Muscular Dystrophy (DMD)
Not applicableEnrolling by invitationLokman Hekim University162026-01-142026-01-27

Showing 20 of 67. Sign in to see all of them.

Narrower conditions

Muscular Dystrophy, Duchenne (67)  ·  Muscular Dystrophies (9)  ·  Neuromuscular Diseases (8)  ·  Muscular Atrophy, Spinal (5)  ·  Cardiomyopathies (4)  ·  Motor Activity (3)  ·  Lower Urinary Tract Symptoms (2)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Cerebral Palsy (1)  ·  Chronic Pain (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)  ·  Heart Failure (1)  ·  Myotonic Dystrophy (1)

Broader conditions

Muscular Diseases (67)  ·  Muscular Disorders, Atrophic (67)  ·  Musculoskeletal Diseases (67)  ·  Nervous System Diseases (67)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (66)  ·  Genetic Diseases, Inborn (66)  ·  Genetic Diseases, X-Linked (66)  ·  Neuromuscular Diseases (59)  ·  Muscular Dystrophies (58)  ·  Neurodegenerative Diseases (6)  ·  Cardiovascular Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Motor Neuron Disease (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Spinal Cord Diseases (5)

Interventions

eteplirsen (3)  ·  Prednisone (2)  ·  idebenone (2)  ·  Cognitive Behavioral Therapy (1)  ·  Drug Evaluation (1)  ·  Exercise (1)  ·  Fitness Trackers (1)  ·  Glucocorticoids (1)  ·  Ibuprofen (1)  ·  Infusions, Intravenous (1)  ·  Isosorbide Dinitrate (1)  ·  Lisinopril (1)  ·  Losartan (1)  ·  Observation (1)  ·  Sodium-Glucose Transporter 2 Inhibitors (1)

Sponsors

Entrada Therapeutics, Inc. (3)  ·  Lokman Hekim University (3)  ·  Peking Union Medical College Hospital (3)  ·  Sarepta Therapeutics, Inc. (3)  ·  Vanderbilt University Medical Center (3)  ·  Centre Hospitalier Universitaire de Liege (2)  ·  Dyne Therapeutics (2)  ·  Grünenthal GmbH (2)  ·  Istanbul University (2)  ·  Istituto Giannina Gaslini (2)  ·  Santhera Pharmaceuticals (2)  ·  Shanghai Jiao Tong University School of Medicine (2)  ·  Aga Khan University (1)  ·  Ankara University (1)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)

Countries

United States (21)  ·  Italy (11)  ·  Turkey (Türkiye) (10)  ·  Belgium (9)  ·  United Kingdom (7)  ·  China (6)  ·  Spain (6)  ·  Netherlands (4)  ·  France (3)  ·  Australia (2)  ·  Austria (2)  ·  Denmark (2)  ·  Egypt (2)  ·  Germany (2)  ·  Ireland (2)

Top investigators

Andreas Giannopoulos, Professor of Pediatrics and Pediatric Cardiology, MD, PhD (1)  ·  Andreas Ziegler, Dr. (1)  ·  Ann Martin, MS, CGC (1)  ·  Benjamin Kozyak, MD (1)  ·  Eliza Wasilewska, MD,PhD (1)  ·  Emilio Clementi (1)  ·  Enrico Bertini, MD (1)  ·  Eric Camino, PhD (1)  ·  Gunnar Buyse, MD PhD (1)  ·  Jiwen Wang (1)  ·  Larry W. Markham, MD (1)

Results publications

PMID 11751186, PMID 15302625, PMID 16055882, PMID 17711917, PMID 21435876, PMID 21921156, PMID 22224768, PMID 22463839, PMID 22496194, PMID 22665702, PMID 23447789, PMID 24459612, PMID 25196721, PMID 26573217, PMID 27566866, PMID 28397169, PMID 29395989, PMID 29395990, PMID 34779542, PMID 38018736, PMID 39063545, PMID 41071520

NIH funding

2025 (3), 2023 (2), R01HD112908 (1), R01HL167969 (1), R61HL180327 (1), U01NS134672 (1)